Uranium prices are on the rise and could go higher still
Although clean-energy funds have been taking a hammering, uranium is the bright spot with scope for further growth.
Clean-energy funds and related equities have taken a hammering this year. The Global Clean Energy ETF (exchange-traded fund) with $3.5bn in assets is the biggest, most liquid green-energy ETF. It has fallen by 26% since 1 January 2023.
UK-focused investors will have noticed an echo of this pain in the investment trust sector. The battery storage industry has been especially badly hit. The three listed funds in this area have suffered huge falls in their share prices:
- Harmony Energy Income Trust (LSE: HEIT) is down by 40% to 75p
- The Gore Street Energy Storage Fund (LSE: GSF) has fallen by 40% to 68p
- The Gresham House Energy Storage Fund (LSE: GRID) has declined by nearly 50% to 88p. (I am a nonexecutive director at GRID.)
This sector had been a market darling as the market for short-duration battery energy storage system (BESS) projects boomed in the UK. According to industry news site Energy Storage News, in recent years the UK market had “ become the largest in Europe with over 3.5GW now online, with projects benefiting from high ancillary service market prices, particularly in 2022”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
That growth resulted in market saturation, which also coincided with falling revenues, partly because the operator of the electricity grid, National Grid, hasn’t opened up as many opportunities as expected in a segment of the market called the balancing mechanism (designed to maintain the stability of power supply). While efforts are being made to give battery storage a more prominent role in the balancing mechanism, investors haven’t stuck around.
Other emerging parts of the clean-energy spectrum are having a better 2023, notably nuclear energy, and especially uranium prices. Over the last few weeks uranium prices have breached the important $60 and $70 a pound barriers. So far this year spot prices have risen by 46% (they are up by 400% since 2019). Unsurprisingly, share prices for uranium miners (and to a lesser degree the small handful of uranium processors) have shot up.
Alternative assets advisory house Ocean Wall runs an index for the small number of stocks in this sector and it has gained 52% in 2023. The market value of global uranium equities is $50bn, made up of just 84 stocks.
Options for UK retail investors
UK investors have two main options to play the uranium rally.
The biggest listed play is Aim-listed Yellowcake (Aim: YCA), which owns a physical reserve – in Canada – of uranium oxide. Its market capitalisation is $1.2bn and with uranium prices above $70/lb, the investment company is trading at a 12% discount to its net asset value (NAV).
Another popular choice is uranium equities fund Geiger Counter (LSE: GCL), which has a NAV of 60p against its current share price of 49.6p, representing an 18% discount. The fund is overweight in US-sourced uranium and owns no Kazatomprom shares. The Kazakh producer is the biggest player globally but is largely state-owned and an integral part of the Russia/ China economic axis. Geiger Counter’s single biggest holding is NexGen Energy, which boasts one of the largest reserves of cheap uranium in a Western jurisdiction. The fund also owns big stakes in America’s Uranium Energy Corporation (7.6%) and Canada’s Fission Uranium Corp. (6.4%).
Over in the ETF sector, one of the most popular ways of buying into the nuclear story is through the HANetf Sprott Uranium Miners UCITS ETF (LSE: URNM). According to HANetf’s Tom Bailey, there’s a decent chance that uranium prices could go even higher from current levels. The uranium spot price “is now only at a comparable level to the spot price right before Fukushima in 2011. In fact, if you were to increase the pre-Fukushima price by inflation, it would be in the high 90s today”. Furthermore, he says, “We are nowhere near the all-time high, which was near $140/lb”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Related articles
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
David Stevenson has been writing the Financial Times Adventurous Investor column for nearly 15 years and is also a regular columnist for Citywire. He writes his own widely read Adventurous Investor SubStack newsletter at davidstevenson.substack.com
David has also had a successful career as a media entrepreneur setting up the big European fintech news and event outfit www.altfi.com as well as www.etfstream.com in the asset management space.
Before that, he was a founding partner in the Rocket Science Group, a successful corporate comms business.
David has also written a number of books on investing, funds, ETFs, and stock picking and is currently a non-executive director on a number of stockmarket-listed funds including Gresham House Energy Storage and the Aurora Investment Trust.
In what remains of his spare time he is a presiding justice on the Southampton magistrates bench.
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published
-
Will the Autumn Budget impact investment markets?
Keir Starmer has warned the Autumn Budget will be “painful”. Will it impact investment markets and should you tweak your portfolio before 30 October?
By Katie Williams Published
-
Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
By Dr Matthew Partridge Published
-
How to invest in the quiet market months
Here's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
By Cris Sholto Heaton Published
-
Spire Healthcare: invest in the booming demand for private healthcare
Spire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
By Rupert Hargreaves Published
-
Are insurance companies a good investment?
Costs may be soaring but the insurance sector is currently going through one of its most profitable periods. The market has been slow to realise the opportunity here
By Rupert Hargreaves Published
-
Google's legal challenges – could it be broken up?
Google is fending off legal challenges from both the EU and the US. But would breaking it up actually work?
By Dr Matthew Partridge Published
-
Fast-growing bargain stocks the market has missed
A professional investor recommends attractive stocks to invest in. This week: Dan Higgins, portfolio manager, Majedie Investments, highlights three favourites
By Dan Higgins Published
-
Are matchboxes worth collecting?
TikTok is reigniting a spark for matchbox collecting. Is there any value in phillumeny or will it fizzle out?
By Chris Carter Published
-
Are shares disconnecting from reality?
What effect is passive investing having on shares, and are ETFs going the same way?
By Alex Rankine Published